Thu, March 26, 2020

Jack Meehan Maintained (BIO) at Buy with Decreased Target to $430 on, Mar 26th, 2020

Jack Meehan of Barclays, Maintained "Bio-Rad Laboratories, Inc." (BIO) at Buy with Decreased Target from $435 to $430 on, Mar 26th, 2020.

Jack has made no other calls on BIO in the last 4 months.



There are 2 other peers that have a rating on BIO. Out of the 2 peers that are also analyzing BIO, 0 agree with Jack's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jack


  • Patrick Donnelly of "Citigroup" Maintained at Strong Buy with Decreased Target to $425 on, Friday, March 20th, 2020
  • Dan Leonard of "Wells Fargo" Maintained at Buy with Increased Target to $440 on, Friday, February 14th, 2020